Drug
Hetrombopag olamine clinical trials
A product of Hetrombopag; its studies count on that page too.
Keep track of what changes. Save the hetrombopag olamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 9
Jiangsu HengRui Medicine Co., Ltd. (15) · Fujian Cancer Hospital (2) · RenJi Hospital (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Peking Union Medical College Hospital (1) · Sir Run Run Shaw Hospital (1) · Huazhong University of Science and Technology (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses hetrombopag olamine is read from its arms, and is right about nine times in ten.
Testing it · 24
- A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT07286032Written as Hetrombopag Olamine
- Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07257809Written as Herombopag Olamine Tablets
- A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingPhase 2Fujian Cancer HospitalNCT07252375Written as herombopag olamine tablets
- Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyNot yet recruitingPhase 2Fujian Cancer HospitalNCT07243418Written as herombopag olamine tablets
- A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06838949Written as herombopag olamine tablets
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingPhase 2Peking Union Medical College HospitalNCT06478537Written as Hetrombopag Olamine
- Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingPhase 2Sir Run Run Shaw HospitalNCT06433830Written as Hetrombopag Olamine
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06346925Written as Herombopag Olamine Tablets
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy SubjectsNot yet recruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06062680Written as Herombopag Olamine Tablets
- Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid LeukemiaNot yet recruitingPhase 2RenJi HospitalNCT05944211Written as Hetrombopag Olamine
- Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT03825744Written as Hetrombopag Olamine+Standard Therapy
- Extension Study of Hetrombopag in Severe Aplastic AnemiaActive, not recruitingPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT04961710Written as Hetrombopag Olamine
- A Bioequivalence Study of Hetrombopag in Healthy SubjectsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05088655Written as Hetrombopag Olamine Tablet
- Herombopag Olamine in the Treatment of Thrombocytopenia After ChemotherapyStatus unknownPhase 4Huazhong University of Science and TechnologyNCT05575986Written as Hetrombopag Olamine
- Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) PatientCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT03222843Written as Hetrombopag Olamine
- A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） PatientCompletedPhase 1/2Jiangsu HengRui Medicine Co., Ltd.NCT03557099Written as Hetrombopag Olamine
- An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownPhase 2Henan Cancer HospitalNCT05252091Written as herombopag olamine tablets
- A Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05088642Written as Hetrombopag Olamine Tablet
- Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human SubjectsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT03977805Written as Hetrombopag Olamine
- A Study to Evaluate Different Intervals Between Dosing and Feeding on the PharmacokineticsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT03603132Written as Hetrombopag Olamine
Codes
What other systems call hetrombopag olamine · ClinicalTrials.gg INT018197
- NCI Thesaurus C173439Hetrombopag OlamineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| NCI Thesaurus | C173439 | Hetrombopag Olamine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.